Inhibition of TGF-β Signaling in Tumor Cells by Small Molecule Src Family Kinase Inhibitors
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
17
Page:
1351-1356
Author(s):
Tobias Bartscht, Benjamin Rosien, Dirk Rades, Roland Kaufmann, Harald Biersack, Hendrik Lehnerta and Hendrik Ungefroren*
Pathological and Therapeutic Aspects of Long Noncoding RNAs in Osteosarcoma
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
17
Page:
1312-1316
Author(s):
Kaixiu Wang, Wei Jiang, Chao Cheng, Yusheng Li* and Min Tu*
Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer
Journal:
Current Pharmaceutical Design
Volume:
23
Page:
3699-3712
Author(s):
Jens Oellgaard*, Signe Abitz Winther, Tobias Schmidt Hansen, Peter Rossing and Bernt Johan von Scholten
Oncostatin M: Potential Implications for Malignancy and Metabolism
Journal:
Current Pharmaceutical Design
Volume:
23
Page:
3645-3657
Author(s):
Jacqueline M. Stephens and Carrie M. Elks*
PTEN, Insulin Resistance and Cancer
Journal:
Current Pharmaceutical Design
Volume:
23
Page:
3667-3676
Author(s):
Aiqing Li*, Minzi Qiu, Hongbo Zhou, Tao Wang and Wen Guo*
AMPK: Therapeutic Target for Diabetes and Cancer Prevention
Journal:
Current Pharmaceutical Design
Volume:
23
Page:
3629-3644
Author(s):
Shotaro Umezawa *, Takuma Higurashi and Atsushi Nakajima
Recent Advances in Substrate Identification of Protein Kinases in Plants and Their Role in Stress Management
Journal:
Current Genomics
Volume:
18
Page:
523-541
Author(s):
Saroj K. Jha, Shikha Malik, Manisha Sharma, Amita Pandey and Girdhar K. Pandey*
Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
Journal:
Current Vascular Pharmacology
Volume:
15
Page:
503-519
Author(s):
Muthu K. Shanmugam, Sudha Warrier, Alan P. Kumar*, Gautam Sethi* and Frank Arfuso
Integration of DNA Methylation Data and Gene Expression Data for Prostate Adenocarcinoma: A Proof of Concept
Journal:
Current Bioinformatics
Volume:
12
Page:
423-430
Author(s):
Arpit Singh, Razia Rahman and Yasha Hasija*
Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors
Journal:
Current Medicinal Chemistry
Volume:
24
Page:
3025-3053
Author(s):
Agnieszka Dreas, Maciej Mikulski, Mariusz Milik, Charles-Henry Fabritius, Krzysztof Brzózka and Tomasz Rzymski*